MERIT-HF


Also found in: Medical.
AcronymDefinition
MERIT-HFMetoprolol CR/XL (Controlled Release/Extended Release) Randomized Intervention Trial in Chronic Heart Failure
References in periodicals archive ?
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure: MERIT-HF Study Group.
In MERIT-HF, the risk of cardiovascular mortality was reduced by 38 percent (placebo: 10.
2) Hjalmarson A et al for the MERIT-HF Study Group, Lancet 1999;353: 2001-7.
However, in the last three years, three major mortality trials -- CIBIS II, MERIT-HF, and COPERNICUS -- have established that bisoprolol, metoprolol and carvedilol cut HF deaths by a third when added to standard therapy with ACE inhibitors and diuretics.
However, in the last three years, three major mortality trials - CIBIS II, MERIT-HF, and COPERNICUS - have established that bisoprolol, metoprolol and carvedilol cut HF deaths by a third when added to standard therapy with ACE inhibitors and diuretics.
The recommended starting doses used in MERIT-HF were 25 mg once daily for patients with NYHA class II heart failure and 12.
However, the results (of BEST) are not inconsistent with those of other studies, specifically MERIT-HF and CIBIS II (previous studies of other beta- blockers in heart failure patients).
MERIT-HF Study Offers New Hope for Heart Failure Patients;